NIRS vs TCD for Cerebrovascular Autoregulation During Non-cardiac Surgery
SONICA
Cerebrovascular Autoregulation During Major Non-cardiac Surgery - a Comparison Between Near Infrared Spectroscopy and Transcranial Doppler Sonography
1 other identifier
observational
509
1 country
1
Brief Summary
Postoperative neurocognitive disorders (NCD) are of high priority in perioperative management. The risk of suffering from NCD after surgery may be increased due to perioperative impairment of cerebrovascular autoregulation and thereby inadequate cerebral perfusion. Cerebrovascular autoregulation refers to the ability of cerebral arterioles to ensure constant cerebral blood flow independently of fluctuations in systemic blood pressure. Cerebrovascular autoregulation can be measured based on mean arterial pressure (MAP) and a surrogate for cerebral blood flow using the correlation method. Until today, measurement of cerebral blood flow velocity assessed with transcranial Doppler sonography (TCD) is most commonly used as a non-invasive surrogate for cerebral blood flow. Alternatively, cerebral oxygenation measured with near-infrared spectroscopy (NIRS) can be used as another surrogate. The study includes three substudies:
- 1.To compare NIRS and TCD for the assessment of perioperative cerebrovascular autoregulation in patients undergoing major non-cardiac surgery with an increased risk of bleeding.
- 2.To compare MAP for optimal cerebrovascular autoregulation before induction of general anesthesia with MAP for optimal cerebrovascular autoregulation during or after general anesthesia.
- 3.To analyze the association between the time-weighted average MAP below the MAP for optimal cerebrovascular autoregulation and postoperative NCD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2021
CompletedFirst Posted
Study publicly available on registry
July 27, 2021
CompletedStudy Start
First participant enrolled
August 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 19, 2024
CompletedOctober 2, 2025
September 1, 2025
2.1 years
July 18, 2021
September 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Equivalence of NIRS-based and TCD-based intraoperative measurement of cerebrovascular autoregulation
calculation of cerebral autoregulation indices based on near-infrared spectroscopy and transcranial Doppler sonography
up to 4 hours during surgery
optimal MAP during NIRS-based measurement of cerebrovascular autoregulation
MAP at lowest cerebral autoregulation index COx
up to 2 hours after surgery
delirium and postoperative NCD after surgery (composite)
screening for postoperative delirium; neuropsychological testing for the assessment of cognitive function
days 1 to 4 after surgery (delirium), day 7 after surgery or at day of discharge from hospital (NCD)
Secondary Outcomes (6)
optimal MAP during TCD-based measurement of cerebrovascular autoregulation
up to 4 hours during surgery
postoperative delirium between day 1 and 4 after surgery
days 1 to 4 after surgery
delayed neurocognitive recovery at day 7 after surgery or before hospital discharge
day 7 after surgery or at day of discharge from hospital
length of hospital stay
date of discharge from hospital (up to 30 days)
length of ICU stay
date of discharge from ICU (up to 30 days)
- +1 more secondary outcomes
Interventions
Continuous monitoring of MAP, cerebral oxygenation, and cerebral blood flow velocity before, during, and after surgery to calculate two cerebrovascular autoregulation indices Cox and Mx.
Eligibility Criteria
Patients scheduled for non-cardiac surgery with general anesthesia at a tertiary care hospital
You may qualify if:
- Age ≥ 18 years
- Elective surgery with a minimum duration of 120 minutes
- General anesthesia
- expected blood loss \> 500 ml
You may not qualify if:
- Temporal bone window failure (substudy 1)
- Cerebrovascular disease
- Cardiac surgery
- Neurosurgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesiology, University Medical Center Hamburg-Eppendorf
Hamburg, 20246, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marlene Fischer, MD, PhD
Universitätsklinikum Hamburg-Eppendorf
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2021
First Posted
July 27, 2021
Study Start
August 9, 2021
Primary Completion
September 29, 2023
Study Completion
September 19, 2024
Last Updated
October 2, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share